Analysis of IFT74 As a Candidate Gene for Chromosome 9P-Linked ALS-FTD Parastoo Momeni National Institutes of Health
Total Page:16
File Type:pdf, Size:1020Kb
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2006 Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD Parastoo Momeni National Institutes of Health Jennifer Schymick National Institutes of Health Shushant Jain National Institutes of Health Mark R. Cookson National Institutes of Health Nigel J. Cairns Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Momeni, Parastoo; Schymick, Jennifer; Jain, Shushant; Cookson, Mark R.; Cairns, Nigel J.; Greggio, Elisa; Greenway, Matthew J.; Berger, Stephen; Pickering-Brown, Stuart; Chiò, Adriano; Fung, Hon Chung; Holtzman, David M.; Huey, Edward D.; Wassermann, Eric M.; Adamson, Jennifer; Hutton, Michael L.; Rogaeva, Ekaterina; St George-Hyslop, Peter; Rothstein, Jeffrey D.; Hardiman, Orla; Grafman, Jordan; Singleton, Andrew; Hardy, John; and Traynor, Bryan J., ,"Analysis of IFT74 as a candidate gene for chromosome 9p- linked ALS-FTD." BMC Neurology.,. 44. (2006). https://digitalcommons.wustl.edu/open_access_pubs/170 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Parastoo Momeni, Jennifer Schymick, Shushant Jain, Mark R. Cookson, Nigel J. Cairns, Elisa Greggio, Matthew J. Greenway, Stephen Berger, Stuart Pickering-Brown, Adriano Chiò, Hon Chung Fung, David M. Holtzman, Edward D. Huey, Eric M. Wassermann, Jennifer Adamson, Michael L. Hutton, Ekaterina Rogaeva, Peter St George-Hyslop, Jeffrey D. Rothstein, Orla Hardiman, Jordan Grafman, Andrew Singleton, John Hardy, and Bryan J. Traynor This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/170 BMC Neurology BioMed Central Research article Open Access Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD Parastoo Momeni†1, Jennifer Schymick†1, Shushant Jain†1, Mark R Cookson1, Nigel J Cairns2,3, Elisa Greggio1, Matthew J Greenway4, Stephen Berger1, Stuart Pickering-Brown5, Adriano Chiò6, Hon Chung Fung1, David M Holtzman2, Edward D Huey7, Eric M Wassermann7, Jennifer Adamson8, Michael L Hutton8, Ekaterina Rogaeva9, Peter St George- Hyslop9, Jeffrey D Rothstein10, Orla Hardiman11, Jordan Grafman7, Andrew Singleton1, John Hardy*1 and Bryan J Traynor12 Address: 1Laboratory of Neurogenetics, National Institute of Aging, NIH, Bethesda, MD, USA, 2Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA, 3Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA, 4Department of Clinical Neurological Sciences Royal College of Surgeons in Ireland, Dublin, Ireland, 5Centre for Clinical Neurosciences, University of Manchester, Greater Manchester Neurosciences Centre, Hope Hospital, Salford, UK, 6Department of Neuroscience, Via Cherasco 15, 10126 Turin, Italy, 7Cognitive Neuroscience Section, National Institute of Neurological Diseases and Stroke, Bethesda, MD 20892, USA, 8Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, Florida, USA, 9Department of Medicine and Physiology, Center for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada, 10Department of Neurology and Neuroscience, Johns Hopkins University, Baltimore, Maryland, USA, 11Department of Neurology, Beaumont Hospital, Dublin 9, Ireland and 12SDGE, National Institute of Mental Health, Bethesda, Maryland, USA Email: Parastoo Momeni - [email protected]; Jennifer Schymick - [email protected]; Shushant Jain - [email protected]; Mark R Cookson - [email protected]; Nigel J Cairns - [email protected]; Elisa Greggio - [email protected]; Matthew J Greenway - [email protected]; Stephen Berger - [email protected]; Stuart Pickering-Brown - [email protected]; Adriano Chiò - [email protected]; Hon Chung Fung - [email protected]; David M Holtzman - [email protected]; Edward D Huey - [email protected]; Eric M Wassermann - [email protected]; Jennifer Adamson - [email protected]; Michael L Hutton - [email protected]; Ekaterina Rogaeva - [email protected]; Peter St George- Hyslop - [email protected]; Jeffrey D Rothstein - [email protected]; Orla Hardiman - [email protected]; Jordan Grafman - [email protected]; Andrew Singleton - [email protected]; John Hardy* - [email protected]; Bryan J Traynor - [email protected] * Corresponding author †Equal contributors Published: 13 December 2006 Received: 03 August 2006 Accepted: 13 December 2006 BMC Neurology 2006, 6:44 doi:10.1186/1471-2377-6-44 This article is available from: http://www.biomedcentral.com/1471-2377/6/44 © 2006 Momeni et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: A new locus for amyotrophic lateral sclerosis – frontotemporal dementia (ALS-FTD) has recently been ascribed to chromosome 9p. Methods: We identified chromosome 9p segregating haplotypes within two families with ALS-FTD (F476 and F2) and undertook mutational screening of candidate genes within this locus. Results: Candidate gene sequencing at this locus revealed the presence of a disease segregating stop mutation (Q342X) in the intraflagellar transport 74 (IFT74) gene in family 476 (F476), but no mutation was detected within IFT74 in family 2 (F2). While neither family was sufficiently informative to definitively implicate or exclude IFT74 mutations as a cause of chromosome 9-linked ALS-FTD, the nature of the mutation observed within F476 (predicted to truncate the protein by 258 amino acids) led us to sequence the open reading frame of this gene in Page 1 of 11 (page number not for citation purposes) BMC Neurology 2006, 6:44 http://www.biomedcentral.com/1471-2377/6/44 a large number of ALS and FTD cases (n = 420). An additional sequence variant (G58D) was found in a case of sporadic semantic dementia. I55L sequence variants were found in three other unrelated affected individuals, but this was also found in a single individual among 800 Human Diversity Gene Panel samples. Conclusion: Confirmation of the pathogenicity of IFT74 sequence variants will require screening of other chromosome 9p-linked families. Background Methods Amyotrophic lateral sclerosis (ALS, Online Mendelian Subjects and samples Inheritance in Man (OMIM) 105400) is characterized by F476 was a four-generation, 15-member North American progressive motor neuron degeneration resulting in paral- ALS-FTD kindred. The proband (figure 2a, III-3) was a 58- ysis and death, usually from respiratory failure, within 3 year-old male with a seven year history of behavioral FTD to 5 years of symptom onset[1]. ALS is typically sporadic symptoms who subsequently developed ALS during the in nature. However, 5–10% of cases are familial, and the course of his illness. His younger brother (III-4) devel- identification of causal mutations has provided insight oped perseveration, lack of insight and dysregulation of into the disease processes that lead to neurodegeneration social and interpersonal conduct at the age of 52. He later [2-5]. Frontotemporal dementia (FTD, OMIM 600274) is developed motor weakness and remains alive three years a degenerative disorder of the frontal and anterior tempo- after disease onset. An older brother (III-1) began show- ral lobes [6] and is the second most common cause of ing poor judgment and inappropriate behavior at 50 years dementia accounting for approximately 20% of pre-senile of age. He died twelve years later with severe dementia. cases [7]. The syndrome is characterized clinically by ini- Marked frontal and anterior temporal lobe atrophy was tial behavioral and psychological disturbances, followed detected at post-mortem. Histology revealed the stereo- by cognitive decline eventually leading to dementia and typical features of frontotemporal lobar degenerations death within a median of seven years from symptom (FTLDs): neuronal loss, microvacuolation, and gliosis onset [8]. There is a family history of dementia in over (figure 3). The frontal lobe was the most severely affected 40% of FTD cases suggesting genetic components [8]. region with focal trancortical neuronal loss. Ubiquitin immunohistochemistry revealed neuronal cytoplasmic Clinical and pathological data indicate that ALS and FTD inclusions, sparse neuronal intranuclear inclusions, and can form a spectrum of disease [9]. Approximately 5% of dystrophic neurites identical to those seen in familial and ALS patients have clinically florid dementia (ALS-FTD) sporadic cases of FTLD with ubiquitin-positive, tau-nega- [10] and roughly half of patients with "classical" ALS have tive inclusions (FTLD-U). There were Bunina bodies in the subtle frontal and temporal lobe impairment [11]. Many motor neurons of the anterior horns of the cervical spinal sporadic and familial FTD cases similarly develop clinical cord, but there was no evidence of corticospinal tract symptoms of motor neuron